• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cancer, obesity, and diabetes: TKIs exert multiple effects on glucose homeostasis.

作者信息

Lin Minglin, Jin Junfei

机构信息

Laboratory of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, 15 Lequn Road, Guilin, 541001, Guangxi, China.

出版信息

Nat Rev Clin Oncol. 2017 May;14(5):268. doi: 10.1038/nrclinonc.2017.56. Epub 2017 Apr 19.

DOI:10.1038/nrclinonc.2017.56
PMID:28422115
Abstract
摘要

相似文献

1
Cancer, obesity, and diabetes: TKIs exert multiple effects on glucose homeostasis.癌症、肥胖与糖尿病：酪氨酸激酶抑制剂对葡萄糖稳态具有多种影响。
Nat Rev Clin Oncol. 2017 May;14(5):268. doi: 10.1038/nrclinonc.2017.56. Epub 2017 Apr 19.
2
Cancer, obesity, and diabetes: TKIs exert multiple effects on glucose homeostasis.
Nat Rev Clin Oncol. 2017 May;14(5):268. doi: 10.1038/nrclinonc.2017.57. Epub 2017 Apr 19.
3
Impaired glucose homeostasis in non-diabetic Greek hypertensives with diabetes family history. Effect of the obesity status.有糖尿病家族史的非糖尿病希腊高血压患者的葡萄糖稳态受损。肥胖状态的影响。
J Am Soc Hypertens. 2013 Jul-Aug;7(4):294-304. doi: 10.1016/j.jash.2013.02.007. Epub 2013 Apr 3.
4
Epidemiology of Gender Differences in Diabetes and Obesity.糖尿病和肥胖症中性别差异的流行病学。
Adv Exp Med Biol. 2017;1043:3-8. doi: 10.1007/978-3-319-70178-3_1.
5
Role of Galectin-3 in Obesity and Impaired Glucose Homeostasis.半乳糖凝集素-3在肥胖症及葡萄糖稳态受损中的作用
Oxid Med Cell Longev. 2016;2016:9618092. doi: 10.1155/2016/9618092. Epub 2015 Dec 6.
6
Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes.英夫利昔单抗可恢复饮食诱导的肥胖和糖尿病动物模型中的葡萄糖稳态。
Endocrinology. 2007 Dec;148(12):5991-7. doi: 10.1210/en.2007-0132. Epub 2007 Aug 30.
7
Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis.在肥胖/2型糖尿病啮齿动物模型中，通过给予瘦素或高脂喂养引起的血糖变化表明抵抗素表达与葡萄糖稳态控制之间存在联系。
Endocrinology. 2004 May;145(5):2206-13. doi: 10.1210/en.2003-1679. Epub 2004 Feb 12.
8
Surgical control of obesity and diabetes: the role of intestinal vs. gastric mechanisms in the regulation of body weight and glucose homeostasis.肥胖和糖尿病的手术治疗：肠道与胃机制在调节体重和葡萄糖稳态中的作用。
Obesity (Silver Spring). 2014 Jan;22(1):159-69. doi: 10.1002/oby.20441. Epub 2013 Aug 1.
9
Changes in inflammatory markers after sleeve gastrectomy in patients with impaired glucose homeostasis and type 2 diabetes.葡萄糖稳态受损和2型糖尿病患者行袖状胃切除术后炎症标志物的变化。
Surg Obes Relat Dis. 2014 Nov-Dec;10(6):1123-8. doi: 10.1016/j.soard.2014.04.019. Epub 2014 Apr 29.
10
Implications of Palmitoleic Acid (Palmitoleate) On Glucose Homeostasis, Insulin Resistance and Diabetes.棕榈油酸（棕榈油酸酯）对葡萄糖稳态、胰岛素抵抗和糖尿病的影响
Curr Drug Targets. 2017;18(6):619-628. doi: 10.2174/1389450117666151209120345.

引用本文的文献

1
Anlotinib induced type 1 diabetes: a case report.安罗替尼诱发1型糖尿病：一例报告
Front Oncol. 2025 Apr 2;15:1508645. doi: 10.3389/fonc.2025.1508645. eCollection 2025.
2
The Impact of Body Mass Index (BMI) on Clinical Outcomes for Patients Receiving Systemic Anti-Cancer Therapies for Advanced Clear Cell Renal Carcinoma.体重指数（BMI）对晚期透明细胞肾细胞癌接受全身抗癌治疗患者临床结局的影响
Cancer Control. 2025 Jan-Dec;32:10732748251317681. doi: 10.1177/10732748251317681. Epub 2025 Mar 17.
3
[Endocrine side effects of tumor treatment].

本文引用的文献

1
Renal-cell carcinoma in 2016: Advances in treatment - jostling for pole position.2016年肾细胞癌：治疗进展——争夺领先地位。
Nat Rev Clin Oncol. 2017 Feb;14(2):82-84. doi: 10.1038/nrclinonc.2016.224. Epub 2017 Jan 10.
2
Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.2型糖尿病与癌症：药物治疗的作用
J Clin Oncol. 2016 Dec 10;34(35):4261-4269. doi: 10.1200/JCO.2016.67.4044. Epub 2016 Nov 7.
3
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?癌症、肥胖、糖尿病和抗糖尿病药物：迷雾正在消散吗？
[肿瘤治疗的内分泌副作用]
Inn Med (Heidelb). 2024 Jul;65(7):681-689. doi: 10.1007/s00108-024-01731-1. Epub 2024 Jun 14.
4
Tyrosine Kinase Inhibitors Reduce Glucose Uptake by Binding to an Exofacial Site on hGLUT-1: Influence on F-FDG PET Uptake.酪氨酸激酶抑制剂通过与 hGLUT-1 的细胞外位点结合减少葡萄糖摄取：对 F-FDG PET 摄取的影响。
Clin Transl Sci. 2021 May;14(3):847-858. doi: 10.1111/cts.12943. Epub 2021 May 3.
Nat Rev Clin Oncol. 2017 Feb;14(2):85-99. doi: 10.1038/nrclinonc.2016.120. Epub 2016 Aug 9.
4
Tyrosine kinase inhibitors under investigation for the treatment of type II diabetes.正在研究的用于治疗 2 型糖尿病的酪氨酸激酶抑制剂。
Expert Opin Investig Drugs. 2016;25(3):287-96. doi: 10.1517/13543784.2016.1142531. Epub 2016 Feb 4.
5
Recurrent hypoglycemia triggered by sorafenib therapy in a patient with hemangiopericytoma.索拉非尼治疗血管外皮细胞瘤患者引起的反复低血糖
Endocrinol Metab (Seoul). 2014 Jun;29(2):202-5. doi: 10.3803/EnM.2014.29.2.202. Epub 2014 Jun 26.
6
Endocrine side effects of anti-cancer drugs: effects of anti-cancer targeted therapies on lipid and glucose metabolism.抗癌药物的内分泌副作用：抗癌靶向治疗对脂代谢和糖代谢的影响。
Eur J Endocrinol. 2014 Feb 1;170(2):R43-55. doi: 10.1530/EJE-13-0586. Print 2014 Feb.
7
Refractory hypoglycemia controlled by sorafenib in solitary fibrous tumor.索拉非尼控制孤立性纤维瘤中的难治性低血糖症
J Clin Oncol. 2013 Mar 20;31(9):e118-21. doi: 10.1200/JCO.2011.40.7999. Epub 2013 Jan 22.
8
Rapid amelioration of hyperglycemia facilitated by dasatinib in a chronic myeloid leukemia patient with type 2 diabetes mellitus.达沙替尼促进一名慢性髓性白血病合并2型糖尿病患者高血糖的快速改善。
Intern Med. 2012;51(19):2763-6. doi: 10.2169/internalmedicine.51.8314. Epub 2012 Oct 1.
9
Impact of sunitinib treatment on blood glucose levels in patients with metastatic renal cell carcinoma.舒尼替尼治疗转移性肾细胞癌患者血糖水平的影响。
Jpn J Clin Oncol. 2012 Apr;42(4):314-7. doi: 10.1093/jjco/hys002. Epub 2012 Feb 9.
10
Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice.酪氨酸激酶抑制剂（舒尼替尼、索拉非尼、达沙替尼和伊马替尼）对一般临床实践中糖尿病和非糖尿病患者血糖水平的影响。
J Oncol Pharm Pract. 2011 Sep;17(3):197-202. doi: 10.1177/1078155210378913. Epub 2010 Aug 4.